Pramlintide: A Novel Therapeutic Approach for Osteosarcoma through Metabolic Reprogramming.

Yang, Yuanzheng; Peng, Zhanglong; Flores, Elsa R; Kleinerman, Eugenie S

Yang, Yuanzheng; Peng, Zhanglong; Flores, Elsa R; Kleinerman, Eugenie S.

Afiliação

Yang Y; Department of Pediatrics Research, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Peng Z; Department of Pediatrics Research, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Flores ER; Department of Molecular Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Kleinerman ES; Department of Pediatrics Research, Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Cancers (Basel) ; 14(17)2022 Sep 02.

Article em En | MEDLINE | ID: mdl-36077845

Palavras-chave

IAPP; glycolytic metabolism; osteosarcoma; p53; p63; p73; pramlintide

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google